Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about KYMR

Recent news which mentions KYMR

< Previous 1 2 3 Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Tickers ACA ADNT ASML AVEO
Tags PASG IAA OYST
From Benzinga
5 Analysts Have This to Say About Kymera Therapeutics
Tickers KYMR
Tags Benzinga KYMR BZI/AAR
From Benzinga
Recap: Kymera Therapeutics Q3 Earnings
Tickers KYMR
Tags KYMR Market News Earnings
From Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
Tickers ALNY CADL CLSN EW
Tags OMER EW Benzinga
From Benzinga
Kymera Gets Orphan Drug Status For Rare Blood Cancer Candidate
Tickers KYMR
Tags Market News FDA Biotech
From Benzinga
Looking Into Kymera Therapeutics's Return On Capital Employed
Tickers KYMR
Tags Earnings Market News KYMR
From Benzinga
Where Kymera Therapeutics Stands With Analysts
Tickers KYMR
Tags Benzinga KYMR BZI/AAR
From Benzinga
Insiders Buying Ecolab, Kymera Therapeutics And This Consumer Cyclical Stock
Tickers ECL KYMR SIX
Tags Trading Ideas News KYMR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2022
Tickers AEL APD ASO AVLR
Tags BZI/Ratings Benzinga PAGP
From Benzinga
During the second quarter, Kymera Therapeutics (KYMR) reported an 8-cent decline in earnings per share
Tickers KYMR
Tags Analyst Rating KYMR News
From Best Stocks
5 Analysts Have This to Say About Kymera Therapeutics
Tickers KYMR
Tags KYMR BZI/AAR Market News
From Benzinga
Kymera Therapeutics: Q2 Earnings Insights
Tickers KYMR
Tags BZI/Recaps Benzinga Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
Tickers AAWW AINV ATHE BNET
Tags NOTE BZI/Ratings HYFM
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022
Tickers A ACLX ALB ALLY
Tags RXDX CVX NFLX
From Benzinga
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Tickers KYMR
Tags Market News Biotech Small Cap
From Benzinga
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Tickers AKRO ATNF BNTX CALA
Tags IBB Contracts MOR
From Benzinga
Why Kymera Therapeutics Stock Is Gaining Wednesday
Tickers KYMR
Tags KYMR News General
From Benzinga
Analyst Ratings for Kymera Therapeutics
Tickers KYMR
Tags Benzinga Analyst Ratings Market News
From Benzinga
Fresh Del Monte Produce And 2 Other Stocks Insiders Are Buying
Tickers FDP KYMR NSIT
Tags Benzinga FDP Insider Trades
From Benzinga
3 Biotech Stocks to Buy Before They Boom
Tickers BHVN GSK IBB JNJ
Tags Stocks to Buy XBI GSK
From InvestorPlace
Executives Buy Around $141M Of 4 Stocks
Tickers APPN IHRT KYMR UBER
Tags IHRT UBER Benzinga
From Benzinga
81 Biggest Movers From Yesterday
Tickers ACON AIKI AIU AKAM
Tags Trading Ideas News IAG
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACON AKAM AMRN ANDE
Tags BWV HBIO SMLP
From Benzinga
80 Biggest Movers From Yesterday
Tickers AERC ARRY ATKR ATNF
Tags SOUN HRMY JAKK
From Benzinga
Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher
Tickers BLTE BORR CHGG ENVX
Tags Earnings CHGG BLTE
From Benzinga
Why Kymera Therapeutics Shares Are Falling Today
Tickers KYMR SNY
Tags Small Cap Guidance Briefs
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Tickers ATNF ATNX BLTE BMEA
Tags KYMR SPRO Intraday Update
From Benzinga
Why Kymera Therapeutics Stock Is Getting Hammered Today
Tickers KYMR PFE SNY
Tags Recent Press Releases KYMR Market News
From Motley Fool
Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge
Tickers BLTE CHGG CVI ENVX
Tags SPRO Commodities PFE
From Benzinga
41 Stocks Moving In Tuesday's Mid-Day Session
Tickers ATKR BLBX BLTE BP
Tags MPWR FN BP
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.